Skip to main content

Table 3 Crude and PS stratified analysis of VTE risk and Hospital Mortality in statin and non-statin groups

From: The association between statin therapy during intensive care unit stay and the incidence of venous thromboembolism: a propensity score-adjusted analysis

Type of analysis HR SE 95% CI P-value
VTE risk
Crude analysis 0.66 0.29 (0.28-1.54) 0.33
PS stratified analysis* 0.63 0.29 (0.25-1.57) 0.33
Hospital Mortality
Crude analysis 1.26 0.18 (0.95-1.68) 0.10
PS stratified analysis* 0.98 0.16 (0.72-1.36) 0.94
  1. *Adjusted for age, APACHE II score, GCS, creatinine, INR, aPTT, Trauma, femoral fracture, central line presence, malignancy, recent surgery, previous VTE, hemodialysis catheter use, use of graduated compression stocking, use of sequential compression device, DVT prophylaxis with unfractionated heparin or enoxaparin, and platelet transfusion.